Facts and figures

HeadquarterDenmark
InternationalInternational production facilities in seven countries.
Affiliates or offices in 75 countries.
WorkforceApproximately 41,500 employees (December 2014).
Approximately 42% of employees are located in Denmark (17,664) and 58% in the rest of the world (North America: 6,465, Japan & Korea: 1,086, China: 5,097, International Operations: 6,666, Europe: 4,472).
18% within research and development
29% in production and production administration
36% in international sales and marketing
17% in administration
Product areas We have four product areas:
Diabetes care 
Haemostasis management
Growth hormone therapy 
Hormone replacement therapy

According to applicable law, only health care professionals are allowed to access the product information on our site. You can find the information under 'Health Care Processionals' in the top menu. For patient and disease information, look under 'Patients'. 
Q4 sales*24,585
Annual sales**88,806 (See our Annual Report for more information)
Sales by business segment* Diabetes care 19,276
Biopharmaceuticals 5,309
Sales by region* North America 12,164
Europe 5,413
International Operations 3,602
China 2,089
Japan & Korea 1,317

Notes
* million Danish kroner, Q4 results 2014
** million Danish kroner, full year results 2014

Novo Nordisk A/S
Bagsværd, Denmark, 
CVR nr. 24 25 67 90

  •  


  •  
  •  

Share information

Learn more about Novo Nordisk shares.

Shareholder rights


  •  
  •  

Novo Nordisk products

Facts about Novo Nordisk products

Product facts

  •